APOCARE Pharma GmbH APOCARE Pharma GmbH
Research and Development

At APOCARE we do not see ourselves merely as suppliers of generics – because since 2003 we have placed great value on independent researchand development of oncological procedures. Pioneering research work on the development of photodynamic therapy (PDT) was carried out in close cooperation with German and international research institutes.

An active substance for use with this technique will be available in the foreseeable future under the product name Fotolon®. Complementary, the possibilities of photodynamic inactivation of bacteria are explored. Comprehensive studies in compliance with international standards are currently being conducted for both research projects.

  • Contact | 
  • APOCARE Pharma GmbH 33647 Bielefeld, Hauptstrasse 198